Paraoxonase-1 Is a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation Through Adipose Stem Cell-Derived Extracellular Vesicles
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312756 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jae Hoon Jung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Pusan National University School of Medicine, Busan 50612, Republic of Korea. Hauptthemen laut MEDLINE: Extracellular Vesicles, Aryldialkylphosphatase, Asthma, Bronchoalveolar Lavage Fluid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although adipose stem cell (ASC)-derived extracellular vesicles (EVs) are as effective as ASCs in the suppression of Th2 cell-mediated eosinophilic inflammation, the role of identified pulmonary genes has not been well documented. Thus, we assessed the immunomodulatory effects of paraoxonase-1 (PON1) on allergic airway inflammation in a mouse model of asthma. Five-week-old female C57BL/6 mice were sensitized to ovalbumin (OVA) by intraperitoneal injection and challenged intranasally with OVA. To evaluate the effect of PON1 on allergic airway inflammation, the intranasal and intraperitoneal injections of recombinant mouse serum PON1 (5 μg/50 μL) were performed before the OVA challenge. We evaluated airway hyperresponsiveness (AHR), total inflammatory cells, and eosinophils in the bronchoalveolar lavage fluid (BALF), lung histology, serum immunoglobulin (Ig), cytokine profiles of BALF and lung draining lymph nodes (LLNs), the expression of interleukin (IL)-25 and transforming growth factor (TGF)-β in mouse lung epithelial cell (MLE-12 cell), and dendritic cell (DC) differentiation. The intraperitoneal and intranasal administration of PON1 significantly decreased AHR, total inflammatory cells and eosinophils in BALF, eosinophilic airway inflammation, serum total, and OVA-specific IgE. PON1 treatment, which marked reduced IL-4, IL-5, and IL-13 in the BALF and LLN but significantly increased interferon-γ and TGF-β. Furthermore, PON1 treatment significantly decreased the expression of IL-25 and increased TGF-β in MLE-12 cells. The expressions of CD40, CD80, and CD86 in immature DCs were significantly increased by PON1 treatment. The administration of PON1 ameliorated allergic airway inflammation and improved AHR through the downregulation of IL-4, IL-5, and IL-13 and upregulation of TGF-β in asthmatic mice. Furthermore, PON1 treatment decreased Th2-mediated inflammation induced by Aspergillus protease antigen by decreasing IL-25 and increasing TGF-β.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Pusan National University School of Medicine, Busan 50612, Republic of Korea.
- Department of Environmental Medical Biology, Catholic Kwandong University College of Medicine, Gangneung 25601, Republic of Korea.
- Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University School of Medicine, Pusan National University Hospital, Busan 50612, Republic of Korea.
- Department of Parasitology and Tropical Medicine, Pusan National University School of Medicine, Busan 50612, Republic of Korea.
- Department of Otorhinolaryngology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Busan 50612, Republic of Korea.
ORCID-Profile: Shin Ae Kang, Ji-Hwan Park, Sung-Dong Kim, Sue Jean Mun
Zitieren
APA
Jung, J. H., Kang, S. A., Park, J. H., Kim, S. D., Yu, H. S., Mun, S. J., & Cho, K. S. (2024). Paraoxonase-1 Is a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation Through Adipose Stem Cell-Derived Extracellular Vesicles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312756
Vancouver
Jung JH, Kang SA, Park JH, Kim SD, Yu HS, Mun SJ, et al. Paraoxonase-1 Is a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation Through Adipose Stem Cell-Derived Extracellular Vesicles. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312756
BibTeX
@article{Jung2024,
author = {Jung, Jae Hoon and Kang, Shin Ae and Park, Ji-Hwan and Kim, Sung-Dong and Yu, Hak Sun and Mun, Sue Jean and Cho, Kyu-Sup},
title = {Paraoxonase-1 Is a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation Through Adipose Stem Cell-Derived Extracellular Vesicles},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312756}
}
EUVIMED